Literature DB >> 18045774

Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice.

Valeria Lamounier-Zepter1, Stefan R Bornstein, Jaroslav Kunes, Jozef Zicha, Michal Krsek, Monika Ehrhart-Bornstein, Christian G Ziegler, Andrea Kiessling, Richard H Funk, Martin Haluzik.   

Abstract

The A-ZIP/F-1 transgenic mouse is a model of lipoatrophic diabetes with severe insulin resistance, hyperglycemia and hyperlipidemia. Recently, a regulatory role of adipose tissue on adrenal gland function and blood pressure has been suggested. To further explore the importance of adipose tissue in the regulation of adrenal function and blood pressure, we studied this mouse model of lipodystrophy. A-ZIP/F-1 mice exhibit significantly elevated systolic and diastolic blood pressure values despite lack of white adipose tissue and its hormones. Furthermore, A-ZIP/F-1 lipoatrophic mice have a significant reduction of adrenal zona glomerulosa, while plasma aldosterone levels and aldosterone synthase mRNA expression remain unchanged. On the other hand, lipoatrophic mice present elevated corticosterone levels but no adrenocortical hyperplasia. Ultrastructural analysis of adrenal gland show significant alterations in adrenocortical cells, with conformational changes of mitochondrial internal membranes and high amounts of liposomes. In conclusion, lipodystrophy in A-ZIP/F-1 mice is associated with hypertension, possibly due to hypercorticosteronemia and/or others metabolic-vascular changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045774     DOI: 10.1016/j.mce.2007.09.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

Review 1.  Mouse models of the metabolic syndrome.

Authors:  Arion J Kennedy; Kate L J Ellacott; Victoria L King; Alyssa H Hasty
Journal:  Dis Model Mech       Date:  2010 Mar-Apr       Impact factor: 5.758

2.  Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing.

Authors:  Juan R Peinado; Pedro M Quirós; Marina R Pulido; Guillermo Mariño; Maria L Martínez-Chantar; Rafael Vázquez-Martínez; José M P Freije; Carlos López-Otín; María M Malagón
Journal:  Mol Cell Proteomics       Date:  2011-08-09       Impact factor: 5.911

3.  A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex.

Authors:  Anelia Horvath; Christoforos Giatzakis; Kitman Tsang; Elizabeth Greene; Paulo Osorio; Sosipatros Boikos; Rossella Libè; Yianna Patronas; Audrey Robinson-White; Elaine Remmers; Jerôme Bertherat; Maria Nesterova; Constantine A Stratakis
Journal:  Eur J Hum Genet       Date:  2008-04-23       Impact factor: 4.246

4.  Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications.

Authors:  Cecile Vernochet; Federico Damilano; Arnaud Mourier; Olivier Bezy; Marcelo A Mori; Graham Smyth; Anthony Rosenzweig; Nils-Göran Larsson; C Ronald Kahn
Journal:  FASEB J       Date:  2014-07-08       Impact factor: 5.191

5.  Effects of angiotensin II type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats.

Authors:  Kumiko Takemori; Takao Inoue; Hiroyuki Ito
Journal:  Lipids Health Dis       Date:  2013-07-22       Impact factor: 3.876

Review 6.  Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.

Authors:  Thiago Bruder-Nascimento; Taylor C Kress; Eric J Belin de Chantemele
Journal:  F1000Res       Date:  2019-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.